This polymorphism, which reduces ALDH2 enzymatic activity to 1%–6% of the wild‐type, is associated with a spectrum of cardiovascular pathologies, including ACS, MI, and atherosclerosis [2, 23]. The gene discussed is ALDH2; the disease is atherosclerosis.